QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (44) Citing Articles via Google Scholar Google Scholar Articles by Pomonis, J. D. Articles by Billington, C. J. Search for Related Content PubMed PubMed Citation Articles by Pomonis, J. D. Articles by Billington, C. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NALOXONE

 Previous Article  |  Next Article 

Volume 17, Number 13, Issue of July 1, 1997 pp. 5175-5182
Copyright ©1997 Society for Neuroscience

Interaction of the Hypothalamic Paraventricular Nucleus and Central Nucleus of the Amygdala in Naloxone Blockade of Neuropeptide Y-Induced Feeding Revealed by c-fos Expression

Received Feb. 19, 1997; revised April 8, 1997; accepted April 11, 1997.

James D. Pomonis¹, Allen S. Levine^{1, 2, 3, 4}, and Charles J. Billington^{2, 3, 4}

¹ Graduate Program in Neuroscience and ² Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, ³ Minnesota Obesity Center, Minneapolis, Minnesota 55417, and ⁴ Veterans Affairs Medical Center, Minneapolis, Minnesota 55417

Neuropeptide Y (NPY) is a powerful inducer of food intake with a key site of action in the paraventricular nucleus (PVN) of the hypothalamus. An effective method for inhibiting the effects of NPY is pretreatment with the opioid antagonists naloxone or naltrexone. In the present study, we used immunohistochemistry for cFos as a marker of neuronal activity to map the effects of PVN-injected NPY and blockade of these effects by peripheral injection of naloxone. Injection of NPY into the PVN resulted in an increase in food intake that was blocked by peripheral administration of naloxone. PVN NPY also resulted in increased cFos immunoreactivity (cFos-IR) in the PVN independent of food intake, and although peripheral naloxone inhibited NPY-induced feeding, it did not alter cFos-IR in the PVN. cFos-IR in the central nucleus of the amygdala (CNA) increased in response to both NPY and naloxone. Furthermore, the response to NPY and naloxone was additive, suggesting that peripheral naloxone and PVN NPY activate different neuronal populations in the CNA. Three other brain regions, the nucleus of the solitary tract, the ventrolateral medulla, and the supraoptic nucleus, all showed increases in cFos-IR in this study, but these changes came only as a result of increased food intake after PVN-injected NPY. The current data suggest that the CNA is a site important for the integration of the NPY and opioid systems.

Key words: neuropeptide Y; feeding; opioids; paraventricular nucleus; central nucleus of the amygdala; nucleus of the solitary tract

This article has been cited by other articles:

				A. Sainsbury, S. Lin, K. McNamara, K. Slack, R. Enriquez, N. J. Lee, D. Boey, G. A. Smythe, C. Schwarzer, P. Baldock, et al. Dynorphin Knockout Reduces Fat Mass and Increases Weight Loss during Fasting in Mice Mol. Endocrinol., July 1, 2007; 21(7): 1722 - 1735. [Abstract] [Full Text] [PDF]

				A. M. Naleid, M. K. Grace, M. Chimukangara, C. J. Billington, and A. S. Levine Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R99 - R105. [Abstract] [Full Text] [PDF]

				F. Y. Obese, B. K. Whitlock, B. P. Steele, F. C. Buonomo, and J. L. Sartin Long-term feed intake regulation in sheep is mediated by opioid receptors J Anim Sci, January 1, 2007; 85(1): 111 - 117. [Abstract] [Full Text] [PDF]

				C. B. Lawrence, A. C. Snape, F. M.-H. Baudoin, and S. M. Luckman Acute Central Ghrelin and GH Secretagogues Induce Feeding and Activate Brain Appetite Centers Endocrinology, January 1, 2002; 143(1): 155 - 162. [Abstract] [Full Text] [PDF]

				M. M. Hagan, S. C. Benoit, P. A. Rushing, L. M. Pritchard, S. C. Woods, and R. J. Seeley Immediate and Prolonged Patterns of Agouti-Related Peptide-(83-132)-Induced c-Fos Activation in Hypothalamic and Extrahypothalamic Sites Endocrinology, March 1, 2001; 142(3): 1050 - 1056. [Abstract] [Full Text] [PDF]

				M. M. Hagan, P. A. Rushing, S. C. Benoit, S. C. Woods, and R. J. Seeley Opioid receptor involvement in the effect of AgRP- (83-132) on food intake and food selection Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R814 - R821. [Abstract] [Full Text] [PDF]

				C. Wang, M. A. Mullet, M. J. Glass, C. J. Billington, A. S. Levine, and C. M. Kotz Feeding inhibition by urocortin in the rat hypothalamic paraventricular nucleus Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R473 - R480. [Abstract] [Full Text] [PDF]

				A. A. Ammar, F. Sederholm, T. R. Saito, A. J. W. Scheurink, A. E. Johnson, and P. Sodersten NPY-leptin: opposing effects on appetitive and consummatory ingestive behavior and sexual behavior Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1627 - R1633. [Abstract] [Full Text] [PDF]

				J. D. Pomonis, D. C. Jewett, C. M. Kotz, J. E. Briggs, C. J. Billington, and A. S. Levine Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R712 - R719. [Abstract] [Full Text] [PDF]

				C. M. Kotz, M. J. Glass, A. S. Levine, and C. J. Billington Regional effect of naltrexone in the nucleus of the solitary tract in blockade of NPY-induced feeding Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R499 - R503. [Abstract] [Full Text] [PDF]

				A. Inui Cancer Anorexia-Cachexia Syndrome: Are Neuropeptides the Key? Cancer Res., September 1, 1999; 59(18): 4493 - 4501. [Abstract] [Full Text] [PDF]

				J. Radulovic, J. Kammermeier, and J. Spiess Relationship between Fos Production and Classical Fear Conditioning: Effects of Novelty, Latent Inhibition, and Unconditioned Stimulus Preexposure J. Neurosci., September 15, 1998; 18(18): 7452 - 7461. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help